How Long Do Benzos Stay In Your System?

Yonder Behavioral Health provides residential addiction treatment and support for individuals and families navigating substance use challenges. Many people are prescribed benzodiazepines, or “benzos,” for anxiety, sleep problems, or seizures. When planning for recovery, prescription management, or drug testing, it can be important to know how long benzos remain in the body.

This article explains what benzodiazepines are, how they work, and what factors affect how long they stay in your system. For more information about treatment options, visit Yonder’s treatment programs.

What Are Benzodiazepines?

Benzodiazepines are medications prescribed by doctors to calm the brain and body. They help treat conditions like anxiety, insomnia, and some types of seizures. These medications work by increasing the effects of a natural brain chemical called GABA, which slows down brain activity.

Benzodiazepines are used in hospitals and clinics, but they can also be misused or lead to dependence. Some of the most common benzodiazepines include:

  • Alprazolam (Xanax): Prescribed for anxiety and panic disorders
  • Diazepam (Valium): Used for anxiety, muscle spasms, and seizures
  • Lorazepam (Ativan): Often given for anxiety and trouble sleeping
  • Clonazepam (Klonopin): Used to manage seizures and panic disorder

In the United States, millions of benzodiazepine prescriptions are written each year. Because these drugs affect the central nervous system, they are usually only given with a doctor’s supervision.

How Do Benzos Affect The Body?

Benzodiazepines attach to special sites called GABA receptors in the brain. By connecting to these receptors, benzodiazepines strengthen the effect of a chemical called GABA, which naturally slows down brain activity. This leads to less anxiety, relaxed muscles, and a sense of calm or sleepiness.

As central nervous system depressants, benzodiazepines can make people feel tired or cause slowed reactions and poor coordination. With regular or long-term use, the body can become dependent on these medications. The liver breaks down benzodiazepines with the help of certain enzymes, and then the kidneys remove the processed drug from the body through urine.

Factors That Influence How Long Benzos Stay In Your System

Detection times for benzodiazepines can vary significantly between individuals. Several factors influence how long benzos remain detectable in your system.

1. Dosage And Frequency of Use

Higher doses and frequent use of benzodiazepines result in longer detection times. Therapeutic doses that are taken as prescribed tend to be eliminated from the body more quickly than larger doses or nonmedical use. Chronic use can lead to accumulation in body tissues, so the drug is detectable even after stopping.

Occasional users usually clear benzodiazepines more quickly, while daily or heavy users may have much longer detection windows due to this buildup.

2. Individual Metabolism And Liver Function

The liver breaks down benzodiazepines using specific enzymes. Some individuals have a faster metabolism or more active liver enzymes, so they process and eliminate benzos more quickly. Others, because of genetics or liver health issues, may metabolize these drugs more slowly.

Differences in metabolism and liver function are a primary reason why detection times are not the same for everyone.

3. Body Composition And Weight

Benzodiazepines are fat-soluble, which means they can be stored in body fat. Individuals with higher body fat percentages may retain benzodiazepines for a longer time because the drug can accumulate in fatty tissues.

Body mass index (BMI) and body composition also play a role. Those with less body fat may clear the drug faster.

4. Age And Overall Health

As people age, metabolism and kidney function often slow down. This change results in longer detection times for benzodiazepines in older adults compared to younger people.

Health conditions that affect the liver or kidneys can also impact how efficiently benzodiazepines are eliminated, leading to prolonged detection.

5. Type of Benzodiazepine And Half-Life

The half-life of a drug is the time it takes for half of the drug to be eliminated from the body. Benzodiazepines can be classified as short-acting, intermediate-acting, or long-acting. The specific type and half-life determine how long the drug stays detectable in the system.

The half-life and chemical properties of each benzodiazepine are key factors in how long the drug will remain in the body.

How Long Do Benzos Stay In Urine, Blood, Hair, And Saliva

Different types of drug tests can find benzodiazepines in the body for different lengths of time. Urine tests are the most common, but blood, hair, and saliva tests are used in some cases. The table below shows how long each test can detect benzodiazepines.

Test Type Detection Window Notes

 

Urine 1-6 weeks Most common test method
Blood 12-24 hours Detects recent use
Hair Up to 90 days Shows long-term use patterns
Saliva 1-10 days Non-invasive testing

1. Urine Detection Windows

Benzodiazepines can be found in urine for 1-6 weeks. The length of time depends on the specific benzodiazepine and how often it is used. Short-term or one-time use is usually detectable for a few days, while long-term or frequent use may be detectable for several weeks. Urine tests are often used because they are easy to collect and can detect the drug for a longer period.

2. Blood Detection Windows

Blood tests can detect benzodiazepines for about 12 to 24 hours after the last dose. These tests are usually used if there is a need to know whether someone has used the drug very recently or is currently affected. Blood tests are less common for general screening.

3. Hair Detection Windows

Benzodiazepines can be detected in hair for up to 90 days. The drug enters the hair as it grows, so hair tests can show a record of use over a longer time. Hair tests cannot show very recent use because it takes time for the drug to appear in new hair.

4. Saliva Detection Windows

Saliva tests can detect benzodiazepines for 1-10 days after use. These tests are easy to use and do not require needles or urine samples. Saliva tests are not always as sensitive as urine or blood tests for finding low levels of the drug.

How Many Days Do Benzos Stay In Your System for Chronic Users?

When benzodiazepines are used regularly over a long period, the drug can build up in the body’s tissues. This buildup can make the drug stay in the system much longer than with occasional use. The length of time benzos are detectable depends on how often and how long they have been used.

For people who have only used benzodiazepines once, tests can usually detect the drug for about 1 to 3 days. If someone uses benzos once a week, the detection window is often 3 to 7 days. For daily use lasting from one to four weeks, the drugs may be found for 1 to 2 weeks after the last dose. In cases of chronic use over several months or years, benzodiazepines can stay in the system for 2 to 6 weeks or even longer.

These detection windows are general estimates and can vary based on individual factors.

Benzodiazepine Half-Life And Elimination Times

The half-life of a benzodiazepine is the amount of time it takes for half of the drug to leave the body. This concept is used to estimate how long a drug remains detectable. Most drugs are considered almost fully eliminated after about five half-lives have passed.

Benzodiazepines are grouped by how long their half-lives last. Short-acting benzodiazepines, such as triazolam and midazolam, have half-lives between 2 and 8 hours. Intermediate-acting benzodiazepines, such as alprazolam and lorazepam, have half-lives between 12 and 24 hours. Long-acting benzodiazepines, such as diazepam, clonazepam, and chlordiazepoxide, have half-lives longer than 24 hours.

The half-life affects how long each type of benzodiazepine can be found in the body. Longer half-lives mean the drug stays in the system longer, while shorter half-lives mean the drug is eliminated more quickly.

Drug Testing Methods And Accuracy

Drug testing for benzodiazepines often begins with an immunoassay screening. This type of test is fast and can detect common benzodiazepines in the body. However, not every benzodiazepine is picked up by an immunoassay, so some types might go undetected.

When a more accurate result is needed, confirmatory testing is used. Gas chromatography-mass spectrometry (GC-MS) is a laboratory method that can precisely identify which benzodiazepine is present. GC-MS is highly specific and can confirm the exact drug and amount.

Sometimes, test results can show a false positive (test says a drug is present when it is not) or a false negative (test misses a drug that is present). This can happen if the test is not sensitive to the specific benzodiazepine or if the cutoff levels are set too high or too low. Certain medications, such as clonazepam, may not appear on standard immunoassay tests and require specialized testing to be detected.

Support for Lasting Recovery

At Yonder Behavioral Health, benzodiazepine dependence is approached with a focus on individualized care. Each person’s treatment plan is tailored to their unique needs and circumstances. Treatment for benzodiazepine dependence may include supervised withdrawal management. Medication support, counseling, and education about substance use are also provided.

Evidence-based therapies, such as cognitive behavioral therapy and group sessions, are used to help individuals identify triggers, build coping skills, and create new habits. Support also includes addressing co-occurring mental health concerns and teaching strategies for long-term wellness.

The treatment environment is designed to be safe and respectful, allowing individuals to focus on healing. Professional staff members provide guidance and support throughout the recovery process. For those seeking help, more information and a way to connect can be found at Yonder Behavioral Health.

Frequently Asked Questions About How Long Benzos Stay In Your System

Can drinking water help benzos leave your system faster?

Drinking water helps the kidneys do their job, but it does not make benzodiazepines leave the body more quickly. The liver is mainly responsible for breaking down benzodiazepines, so increased water intake has little effect on how fast the drug is eliminated.

Do all benzodiazepines show up on standard drug tests?

Not all benzodiazepines appear on standard drug tests. Some, such as clonazepam, may go undetected by basic immunoassay screens and require specific confirmatory testing to be identified.

How long after stopping benzos is it safe to drive?

The time it is safe to drive after stopping benzodiazepines varies based on the type of medication and a person’s individual health. A healthcare provider can give guidance based on these factors.

Can benzodiazepines be detected in a newborn if taken during pregnancy?

Benzodiazepines can cross the placenta during pregnancy and may be present in a newborn’s system. Medical supervision during pregnancy is important if benzodiazepines are being used.

Compassionate, Comprehensive, and Personalized Care

These three ideas help define the care experience at Yonder Behavioral Health.

Compassionate care means you are treated like a person, not a problem. Our team knows it can be hard to ask for help, so we work to create a respectful, supportive space from the very beginning.

Comprehensive care means we look at the full picture of your life and health. Because addiction often overlaps with trauma, stress, and mental health concerns, treatment should address more than substance use alone.

Personalized care means your treatment plan is built around your needs, goals, and progress. Since recovery looks different for each person, the support you receive should feel specific, flexible, and relevant.

Franklin Bland, Executive Director at Yonder Behavioral Health

Franklin Bland serves as Executive Director of Yonder Behavioral Health, bringing more than a decade of experience in the substance use disorder treatment field and a longstanding commitment to developing strong, compassionate teams.

Franklin holds a Bachelor of Health Administration from Capella University and has served in a variety of leadership roles throughout the SUD treatment field. He is intimately familiar with processes from the first call, to the ride to the next step in the recovery journey for those he has the honor of providing care for. Prior to entering healthcare, he spent approximately 20 years building and managing teams in the construction industry. Together, these experiences have shaped a leadership style centered on accountability, collaboration, mentorship, and the belief that exceptional client care begins with a cohesive and supported staff.

As a Mandt-trained leader, Franklin places a strong emphasis on trauma-informed care and expects staff interactions with patients to reflect dignity, respect, compassion, and an understanding of each individual’s experiences. He is passionate about mentoring employees, developing future leaders, and helping team members identify opportunities to advance in their own careers.

Franklin believes effective treatment must respect client autonomy, individual choice, and person-centered care. He recognizes that recovery is deeply personal and that there is no single path that works for everyone.

“Not all recovery looks the same, and every human deserves the chance to recover.”

As Executive Director, Franklin works to foster a culture in which compassionate care and accountability go hand in hand. He places a high value on interdepartmental collaboration and believes every department has a role in creating an environment where clients can feel safe, respected, and empowered to pursue lasting recovery.

Dr. William Cooke, Medical Director at Yonder Behavioral Health

Dr. William Cooke is the Medical Director of Yonder Behavioral Health, an inpatient facility dedicated to providing comprehensive and compassionate care for individuals struggling with substance use disorders. With over two decades of experience in addiction medicine, Dr. Cooke leads the clinical team with a focus on evidence-based practices and patient-centered care.

As a board-certified expert in both Family Medicine and Addiction Medicine, Dr. Cooke brings a holistic approach to treatment, integrating medical, psychological, and social support to address the complex needs of individuals on their journey to recovery. Under his leadership, Yonder BH emphasizes a “whole-person” philosophy, ensuring that each patient receives tailored treatment plans that foster long-term recovery and overall well-being.

Dr. Cooke is also a Fellow of the American Society of Addiction Medicine (ASAM), reflecting his commitment to advancing the field of addiction medicine through continuous learning, advocacy, and collaboration. He is dedicated to creating a safe, supportive, and effective environment where patients can begin their path to healing.

Norma Edwards is an accomplished Human Resources professional with more than 30 years of experience across human resources leadership, employee relations, recruitment, compliance, and organizational development. She has a proven track record of establishing and strengthening HR departments, developing effective systems and processes, and partnering with organizational leadership to support a strong and positive workplace culture.

Currently, Norma serves as Director of Human Resources at Yonder Behavioral Health / Aspen BHC, where she is an active member of the Leadership Team. She oversees all aspects of human resources and plays an integral role in supporting organizational compliance and operational effectiveness.

Throughout her career, Norma has successfully led human resources initiatives within new, rapidly growing, and established organizations. She is particularly experienced in building HR infrastructure from the ground up, developing effective policies and processes, and establishing collaborative partnerships with leaders throughout an organization.

Her professional experience spans the behavioral health, nonprofit, and hospitality industries, providing her with a broad perspective on workforce management, organizational culture, and employee engagement.

Jordan serves as the Director of Nursing at Yonder Behavioral Health and is passionate about helping individuals find hope, healing, and lasting recovery. She believes that every person deserves to be treated with dignity, compassion, and respect, especially during life’s most challenging moments.

Throughout her nursing career, Jordan has been dedicated to supporting individuals on their journey toward better health and wellness. Her approach is grounded in empathy, understanding, and the belief that meaningful connections can make a lasting impact on recovery.

Jordan is passionate about creating a supportive environment where patients feel safe, valued, and empowered to make positive changes in their lives. She is equally committed to encouraging teamwork, growth, and compassion among those who have the privilege of caring for others.

A strong advocate for recovery-focused care, Jordan believes in meeting people where they are and supporting them every step of the way. Her dedication to helping others and commitment to Yonder Behavioral Health’s mission continue to inspire patients and colleagues alike.

“I believe that every person deserves hope, compassion, and the opportunity to heal. Recovery is a journey, and it’s an honor to walk alongside individuals as they rediscover their strength and potential.”

Joshua Sherbert is a Kentucky native and serves as Program Director at Yonder Behavioral Health. He is passionate about creating a strong recovery culture built on connection, accountability, and support. Joshua believes in meeting people where they are while challenging them to recognize what they are capable of.

What he enjoys most about his work is building meaningful connections, developing a strong team, and watching people begin to believe in themselves as they build a better life through recovery.

Keisha Jones, LCSW, is an experienced behavioral health leader and licensed clinical social worker specializing in substance use disorder treatment, clinical operations, and patient-centered care. She earned her Master of Social Work degree from Campbellsville University, providing the foundation for a career dedicated to improving the lives of individuals and families impacted by mental health and substance use disorders.

With extensive experience in clinical leadership, Keisha has a strong background in developing high-performing teams, supervising and supporting clinicians, improving clinical programming, and maintaining high standards of quality and regulatory compliance. Her experience includes overseeing multidisciplinary clinical services, strengthening treatment programs, and promoting evidence-based, person-centered approaches to care.

Keisha is passionate about creating treatment environments where both patients and professionals can thrive. Her leadership approach emphasizes collaboration, accountability, compassion, and open communication while maintaining a strong commitment to clinical excellence.

Throughout her career, Keisha has remained dedicated to advancing the quality of behavioral health and addiction treatment and helping individuals build meaningful, sustainable lives in recovery.